Immunotherapy Significantly Extends Survival Post-Kidney Cancer Surgery

1 year ago 29

In the KEYNOTE 564 study, investigators have found pembrolizumab effective in improving survival post kidney cancer removal surgery.

1. Homepage
2. category-label-
3. Immunotherapy Significantly Extends Survival Post-Kidney Cancer Surgery